Literature DB >> 30565299

Variants and new entities of bladder cancer.

Antonio Lopez-Beltran1, Vanessa Henriques2, Rodolfo Montironi3, Alessia Cimadamore3, Maria R Raspollini4, Liang Cheng5.   

Abstract

Pathological evaluation of bladder cancer typically reveals great tumour heterogeneity, and therefore the common observation of urothelial carcinoma exhibiting a wide variety of histopathological patterns is not surprising. Some of these patterns are so distinctive that they have been recognised as specific variants of urothelial carcinoma. Classifications have recently been revised in the 2016 World Health Organisation (WHO) classification of tumours of the urinary system and male genital organs. The current WHO classifications clarify terminological issues and provide better definition criteria, but also incorporate some new entities. Many of these variants have important prognostic or therapeutic implications worth knowing by the urologist and oncologist, but also represent diagnostic challenges in daily pathology practice. This review will discuss the features of variants of urothelial carcinoma in the context of our current clinical practice. Histological variations and new entities of bladder cancer not included in the current WHO classification of urothelial tumours will be briefly discussed.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  bladder carcinoma; clear cell; giant pleomorphic; glandular; lymphoepithelioma-like; microcystic; micropapillary; nested; plasmacytoid; squamous; variant histology

Mesh:

Year:  2019        PMID: 30565299     DOI: 10.1111/his.13752

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  25 in total

1.  Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach?

Authors:  Luca Afferi; Stefania Zamboni; Philipp Baumeister; Livio Mordasini; Agostino Mattei; Marco Moschini
Journal:  Transl Androl Urol       Date:  2019-07

2.  Microcystic urothelial carcinoma: a case report.

Authors:  Mengyao Liu; Shuaichen Liu; Lei Bao; Weiyi Chen; Ping Yang; Huihui Zhou
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

3.  Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.

Authors:  Sungmin Woo; Soleen Ghafoor; Jeeban P Das; Natalie Gangai; Alvin C Goh; Herbert Alberto Vargas
Journal:  Urol Oncol       Date:  2021-11-05       Impact factor: 3.498

Review 4.  [Immunological biomarker research in uro-oncology-using the example of urothelial cancer].

Authors:  Markus Eckstein
Journal:  Urologie       Date:  2022-05-30

5.  A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.

Authors:  Christophe Bontoux; Thomas Rialland; Olivier Cussenot; Eva Compérat
Journal:  Virchows Arch       Date:  2020-10-30       Impact factor: 4.064

Review 6.  Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.

Authors:  Manju Aron
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

Review 7.  Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.

Authors:  Joshua J Meeks; Hikmat Al-Ahmadie; Bishoy M Faltas; John A Taylor; Thomas W Flaig; David J DeGraff; Emil Christensen; Benjamin L Woolbright; David J McConkey; Lars Dyrskjøt
Journal:  Nat Rev Urol       Date:  2020-03-31       Impact factor: 14.432

8.  Cases - Clear-cell urothelial carcinoma of the bladder.

Authors:  Carolyn MacLeod; Ernest P Chan; Kamilia Rizkalla; Alp Sener; Jeffrey Campbell
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

9.  Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.

Authors:  Nicolas Epaillard; Pauline Parent; Yohann Loriot; Pernelle Lavaud; E-B Vera-Cea; Nieves Martinez-Chanza; Alejo Rodriguez-Vida; Clement Dumont; Rebeca Lozano; Casilda Llácer; Raffaele Ratta; Stephane Oudard; Constance Thibault; Edouard Auclin
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  Giant Cell Urothelial Carcinoma of Bladder.

Authors:  Harshima Disvini Wijesinghe; Ajith Malalasekera
Journal:  Case Rep Urol       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.